| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.006 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.45 | 0.007 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |